adrenalin (epinephrine in sodium chloride)

Generic: epinephrine in sodium chloride

Labeler: par health usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name adrenalin (epinephrine in sodium chloride)
Generic Name epinephrine in sodium chloride
Labeler par health usa, llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

epinephrine 40 ug/mL

Manufacturer
Par Health USA, LLC

Identifiers & Regulatory

Product NDC 42023-721
Product ID 42023-721_b8168d6f-0dcf-45ae-81d8-a377ff8b26a7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215875
Listing Expiration 2026-12-31
Marketing Start 2025-05-14

Pharmacologic Class

Established (EPC)
alpha-adrenergic agonist [epc] beta-adrenergic agonist [epc] catecholamine [epc]
Mechanism of Action
adrenergic alpha-agonists [moa] adrenergic beta-agonists [moa]
Chemical Structure
catecholamines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42023721
Hyphenated Format 42023-721

Supplemental Identifiers

RxCUI
2695029 2695032 2707356 2707359 2713737 2713740 2719203 2719204 2719206 2719209
UNII
YKH834O4BH
NUI
N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name adrenalin (epinephrine in sodium chloride) (source: ndc)
Generic Name epinephrine in sodium chloride (source: ndc)
Application Number NDA215875 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 40 ug/mL
source: ndc
Packaging
  • 10 BAG in 1 CARTON (42023-721-10) / 250 mL in 1 BAG (42023-721-01)
source: ndc

Packages (1)

Ingredients (1)

epinephrine (40 ug/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "b8168d6f-0dcf-45ae-81d8-a377ff8b26a7", "openfda": {"nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "unii": ["YKH834O4BH"], "rxcui": ["2695029", "2695032", "2707356", "2707359", "2713737", "2713740", "2719203", "2719204", "2719206", "2719209"], "spl_set_id": ["61b0e2a2-71ed-43d6-b1a7-36d2dae651b5"], "pharm_class_cs": ["Catecholamines [CS]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "manufacturer_name": ["Par Health USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BAG in 1 CARTON (42023-721-10)  / 250 mL in 1 BAG (42023-721-01)", "package_ndc": "42023-721-10", "marketing_start_date": "20250514"}], "brand_name": "Adrenalin (epinephrine in sodium chloride)", "product_id": "42023-721_b8168d6f-0dcf-45ae-81d8-a377ff8b26a7", "dosage_form": "INJECTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Catecholamine [EPC]", "Catecholamines [CS]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "42023-721", "generic_name": "Epinephrine in Sodium Chloride", "labeler_name": "Par Health USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adrenalin (epinephrine in sodium chloride)", "active_ingredients": [{"name": "EPINEPHRINE", "strength": "40 ug/mL"}], "application_number": "NDA215875", "marketing_category": "NDA", "marketing_start_date": "20250514", "listing_expiration_date": "20261231"}